RecruitingAlzheimers Disease

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

Eligible age

50–90 yrs

Accepts

All genders

Locations

24 states

Healthy volunteers

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

This study is a pre-screening process used to assess participants' potential eligibility for Roche interventional Alzheimer's disease studies.

Sponsor: Hoffmann-La Roche

✓ \- Report of objective or subjective memory concerns (by the participant and/or their informant) within the last year with or without a previous clinical diagnosis of MCI or dementia due to AD.

✕ Dependency in basic activities of daily living (bADLs) due to cognitive impairment
✕ Visual or auditory impairment that would prevent them from performing the cognitive assessments (eyeglasses and hearing aids are permitted)
✕ Any self-reported evidence or known diagnosis of a neurological or neurodegenerative condition that may lead to cognitive impairment other than AD
✕ History of severe, clinically significant central nervous system trauma
✕ Any serious medical condition that precludes a participant's safe participation and completion of a clinical study